Exogenous Oestrogens and the Risk of Breast Cancer 1

Abstract

Get full access to this article

View all access options for this article.

References

Kelsey

(ed).Breast cancer. Epidemiologic Reviews 1993; 15:7–263.

Hulka

Stark

. Breast cancer: cause and prevention. Lancet 1995; 346:883–7.

Mant

Vessey

. Epidemiology and primary prevention of breast cancer. In: Bland

Copeland

(eds) The breast. Comprehensive management of benign and malignant diseases Philadelphia:WB Saunders, 1991.

Murphy

MFG

Broeders

MJM

Carpenter

. Breast cancer risk in mothers of twins. Br J Cancer 1997; 75:1066–8.

Key

TJA

Wang

Brown

. A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 1996; 73:1615–9.

Hankinson

Willett

Manson

. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90:1292–9.

Smith

G van S

. The influence of diethylstilboestrol on the progress and outcome of pregnancy as based on a comparison of treated with untreated primigravidas. Am J Obstet Gynecol 1949; 58:994–1005.

Brackbill

Berendes

. Dangers of diethylstilboestrol: a review of a 1953 paper. Lancet 1978; ii:520.

Herbst

Ulfelder

Poskanzer

. Adenocarcinoma of the vagina. Association of maternal stilboestrol therapy with tumour appearance in young women. N Engl J Med 1971; 284:878–81.

10.

Hatch

Palmer

Titus-Ernstoff

. Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 1998; 280:630–4.

11.

Colton

Greenberg

Noller

. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. JAMA 1993; 269:2096–100.

12.

Calle

Mervis

Thun

. Diethylstilboestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol 1996; 144:645–52.

13.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347:1713–27.

14.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: further results. Contraception 1996; 54(suppl):1S-106S.

15.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350:1047–59.

16.

DiSaia

Grosen

Kurosaki

. Hormone replacement therapy in breast cancer survivors: a cohort study. Am J Obstet Gynecol 1996; 174:1494–8.

17.

Beral

Banks

Reeves

Wallis

. Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet 1997; 349:1103–4.

18.

Harvey

Pinkerton

Herman

. Short-term cessation of hormone replacement therapy and improvement of mammographic specifity. J Natl Cancer Inst 1997; 89:1623–5.

19.

Laya

Larson

Taplin

White

. Effect of estrogen replacement therapy on the specifity and sensitivity of screening mammography. J Natl Cancer Inst 1996; 88:643–9.